Advac Elastomers of Wisconsin Inc. recently received approval for a $470,000 loan from the Milwaukee Economic Development Corp. Advac plans to operate within a 110,000-square-foot building at ...
AdVac technology is based on adenoviruses that occur less frequently in the human population, such as Ad26 and Ad35. In contrast to, for instance, Ad35 antibodies, antibodies to Ad5 are widespread ...
First human trial of the MVA-BN® Filo/AdVac® preventative Ebola vaccine regimen initiated in the UK Additional trials soon to be initiated in United States and Africa Company now expects 2 million ...
DUBLIN – Johnson & Johnson’s Janssen Biotech arm is on the brink of a historic first vaccine approval, having secured a positive vote May 29 from the EMA’s Committee for Medicinal Products for Human ...
Leiden, the Netherlands (August 11, 2010) - Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announces its intention to participate in an ...